Cannabidiol Oral Solution (Benuvia Therapeutics/Radius Health)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameCannabidiol Oral Solution (Benuvia Therapeutics/Radius Health)
Drug Alias NameSynthetic cannabidiolPharmaceutical cannabidiol (CBD)RAD-011
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB2 receptorCannabinoid CB1 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsPainSeizuresPrader-Willi Syndrome +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInsys Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsys Therapeutics IncRadius Pharmaceuticals, IncUniversity Of California, Los Angeles
Active IndicationsN/A
Inactive IndicationsPainSeizuresPrader-Willi Syndrome +[7] 

Other Information

ATC CodeN/A
Related LinksN/A